Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Where does the combination of sorafenib and interferon in renal cell carcinoma stand?

Where does the combination of sorafenib and interferon in renal cell carcinoma stand? Cancer. 2010 Jan 01; 116(1):4-7.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.